Little European biotech Sotio nabs a super $316M funding round for its superagonist worknews2021-12-03T10:22:06+00:00December 3rd, 2021|FierceBiotech|
BeyondSpring lurches down as FDA rejects plinabulin, raising questions about lung cancer prospectsnews2021-12-03T08:48:53+00:00December 3rd, 2021|FierceBiotech|
Fore fires CEO Malik after SEC insider trading charges during his time as Immunomedics CFOnews2021-12-02T17:52:03+00:00December 2nd, 2021|FierceBiotech|
Alpha challenger: Novartis pays UCB $150M to join Roche, AstraZeneca in Parkinson’s racenews2021-12-02T12:48:01+00:00December 2nd, 2021|FierceBiotech|
GlaxoSmithKline, University of Oxford join forces in $40M digital deep dive into neuronews2021-12-02T10:40:29+00:00December 2nd, 2021|FierceBiotech|
Tune Therapeutics’ epigenetic platform resonates with investors as it snags $40M in financingnews2021-12-01T17:58:03+00:00December 1st, 2021|FierceBiotech|
Aclaris’ experimental rheumatoid arthritis drug bolsters chemo in pancreatic cancer modelsnews2021-12-01T15:54:55+00:00December 1st, 2021|FierceBiotech|
Astellas becomes latest Dyno gene therapy partner with $1.6B biobucks pact to join Roche, Novartis, Sareptanews2021-12-01T14:58:07+00:00December 1st, 2021|FierceBiotech|
Vertex once again talks up a tiny trial with positive read-throughs, this time for a genetically driven approach to kidney diseasenews2021-12-01T13:08:52+00:00December 1st, 2021|FierceBiotech|
J&J cell therapy head exits to take up post at fledgling biotechnews2021-12-01T12:43:21+00:00December 1st, 2021|FierceBiotech|
